MENU
+Compare
IONS
Stock ticker: NASDAQ
AS OF
Oct 14, 02:49 PM (EDT)
Price
$71.80
Change
+$1.21 (+1.71%)
Capitalization
11.15B

IONS Ionis Pharmaceuticals Forecast, Technical & Fundamental Analysis

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs... Show more

Industry: #Biotechnology
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IONS with price predictions
Oct 13, 2025

Aroon Indicator for IONS shows an upward move is likely

IONS's Aroon Indicator triggered a bullish signal on October 13, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 211 similar instances where the Aroon Indicator showed a similar pattern. In of the 211 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 26, 2025. You may want to consider a long position or call options on IONS as a result. In of 97 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IONS advanced for three days, in of 279 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 11 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Moving Average Convergence Divergence Histogram (MACD) for IONS turned negative on October 07, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 53 similar instances when the indicator turned negative. In of the 53 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IONS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

IONS broke above its upper Bollinger Band on October 02, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IONS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.825) is normal, around the industry mean (24.216). P/E Ratio (0.000) is within average values for comparable stocks, (54.710). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (11.669) is also within normal values, averaging (342.828).

View a ticker or compare two or three
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IONS is expected to report earnings to fall 274.29% to -122 cents per share on October 30

Ionis Pharmaceuticals IONS Stock Earnings Reports
Q3'25
Est.
$-1.22
Q2'25
Beat
by $0.94
Q1'25
Beat
by $0.15
Q4'24
Beat
by $0.45
Q3'24
Beat
by $0.17
The last earnings report on July 30 showed earnings per share of 69 cents, beating the estimate of -23 cents. With 208.35K shares outstanding, the current market capitalization sits at 11.15B.
A.I. Advisor
published General Information

General Information

a developer of antisense drugs

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2855 Gazelle Court
Phone
+1 760 931-9200
Employees
927
Web
https://www.ionispharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SDCI22.790.31
+1.38%
USCF SummerHaven Dyn CmdtyStgy NoK-1 ETF
PWZ24.240.16
+0.66%
Invesco California AMT-Free Muni Bd ETF
IBMT26.040.13
+0.50%
iShares iBonds Dec 2031 Term Muni Bd ETF
PCEM11.09N/A
N/A
Polen Capital Em Mkts ex-China Gr ETF
DXD22.36-0.58
-2.53%
ProShares UltraShort Dow30

IONS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, IONS has been loosely correlated with CYTK. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if IONS jumps, then CYTK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IONS
1D Price
Change %
IONS100%
+0.89%
CYTK - IONS
64%
Loosely correlated
-0.75%
MLYS - IONS
51%
Loosely correlated
+2.11%
ARWR - IONS
51%
Loosely correlated
+2.37%
MNKD - IONS
48%
Loosely correlated
+4.51%
RARE - IONS
48%
Loosely correlated
+1.81%
More